Triducive®

“The NHS is spending a fortune giving people a death they don't want” #nhs #bbc

This March, at #AlfasigmaUKIE, we are committed to supporting #AutoimmuneAwarenessMonth to raise awareness for individuals affected by autoimmune conditions, in particular #RheumatoidArthritis (RA) and #InflammatoryBowelDisease (IBD). To kickstart the month we are focusing on RA, by working to raise awareness and evolve society’s understanding of the everyday challenges faced by people living with the condition. Autoimmune diseases all stem from the immune system mistakenly attacking and damaging healthy tissues and cells. In the case of RA, this process specifically affects the joints, causing them to become inflamed, swollen, and painful. For these individuals, this means daily activities can become increasingly difficult due to persistent discomfort and reduced mobility. By sharing knowledge and supporting vital research, we’re empowering individuals affected by RA, helping them navigate their journey with confidence to regain control of their lives. 

It's brilliant to have you join the team, Rachel 👏

Over 300 million decisions need to be actioned in terms of rare diseases. On #rarediseaseday 2025, Triducive® wish to acknowledge, celebrate and support all those involved in such decisions. By definition, rare diseases affect a small number of individuals (fewer than 1 in 2000 people in any WHO region); yet, with more than 7000 types of rare disease in existence, the burden worldwide is not insignificant. To date, approximately 300 million people live with rare diseases. https://lnkd.in/eVhuvsDY. #thelancet #RareDiseaseDay

I rarely use LinkedIn to ask for help but this is different. The Rare Cancers Bill - if it becomes law - has the potential to bring about significant change for people with rare cancers, including brain tumours. Please take action by writing to your MP. If you’re not sure what to write, visit The Brain Tumour Charity where there is a draft letter you can personalise and use. At least 100 MPs must attend the debate in Parliament on Friday 14 March to help this Bill become law - so spread the word.

👇 The study we've been eagerly awaiting publication of: 'Results of a modified Delphi consensus on the optimal testing pathway for oesophago-gastric cancer care in the UK' in the BMJ (link in comments) Oesophago-gastric (OG) cancers are the 5th most common cancer in the UK, with 13,000 new cases diagnosed annually. Oesophageal cancer accounts for 72% of these cases, and treatment heavily relies on biomarkers like HER2 and PD-L1. Unfortunately, 44% of patients are diagnosed at stage 4, and 69% face delays, waiting longer than the 62-day target for treatment. We’re incredibly proud that the British Medical Journal (BMJ) has accepted our Delphi study for publication. This research is a pivotal step toward addressing the urgent need to reduce delays and improve outcomes for OG cancer patients across the UK. #CancerCare #HealthcareInnovation #OGCancer #UKHealth #BiomarkerTesting

Over 300 million decisions need to be actioned in terms of rare diseases. On #rarediseaseday 2025, Triducive® wish to acknowledge, celebrate and support all those involved in such decisions. By definition, rare diseases affect a small number of individuals (fewer than 1 in 2000 people in any WHO region); yet, with more than 7000 types of rare disease in existence, the burden worldwide is not insignificant. To date, approximately 300 million people live with rare diseases. https://lnkd.in/eVhuvsDY. #thelancet #RareDiseaseDay

Yes!

Decades of resilient public health advocacy, sustained investment and continuous biomedical innovation has transformed the collective response to the HIV epidemic. Despite this progress, the HIV epidemic is far from over. Countries across the world are at risk of not reaching/achieving the UNAIDS goal to end the HIV epidemic by 2030. With less than 2,000 days to go before 2030, we stand at a critical juncture. Gilead Sciences has led a series of sponsored articles in the Financial Times Times on how to accelerate progress toward eradicating the virus, grounded in findings from the Going the Extra Mile to End the HIV Epidemic report. It contains valuable insights from change makers and thought leaders in HIV including Mercy Shibemba Junko Tanuma Ian Jackson Jane Anderson. I believe that together, ending the HIV epidemic is possible – but only if collective action is taken today to drive urgency and political action. Read more here 👇: ·        Now is the time to end the HIV epidemic: why action must be taken https://lnkd.in/ezBzqfMj. Harnessing innovation to accelerate progress and end the HIV epidemic by 2030 https://lnkd.in/eBu8iZCa ·        The expansion of HIV testing to achieve the previously unthinkable https://lnkd.in/eiK2ZjRM

This week marks the 20th anniversary of NBC News’ "Autism: The hidden epidemic?," for which I served as coordinating producer. I wrote this article to reflect on our progress. Despite strides, we’ve fallen short of the breakthroughs envisioned twenty years ago. As a community, we must act with greater urgency—uncovering the true causes of autism and delivering transformative treatments.